In bladder cancer, genes involved in Wnt signaling are rarely mutated but epigenetic deregulation and deletion of sFRP1, coding for a Wnt pathway antagonist, has been reported in 25% of tumors36. The gene discussed is SFRP1; the disease is urinary bladder carcinoma.